Dosing & Uses
Noncystic Fibrosis Bronchiectasis
Pending FDA approval for patients with noncystic fibrosis bronchiectasis (NCFBE) who have chronic lung infections caused by P aeruginosa
Next:
Pharmacology
Mechanism of Action
Fluoroquinolone antibiotic
Mixture of liposome encapsulated and unencapsulated slow-release inhaled formulation of ciprofloxacin
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
